Trials / Unknown
UnknownNCT01019863
Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Centre de recherche du Centre hospitalier universitaire de Sherbrooke · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the efficacy, tolerance, quality of life and cost effectiveness of the association of Oxaliplatin, Gemcitabine, Rituximab and Dexamethasone for treatment of patients with refractory or relapsing non-Hodgkin lymphoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oxaliplatin | oxaliplatin 100mg/m2 + Rituxan 375 mg/m2 + Gemcitabine 1000mg/m2 every 2 weeks for 8 cycles |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2010-10-01
- Completion
- 2011-10-01
- First posted
- 2009-11-25
- Last updated
- 2011-01-12
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01019863. Inclusion in this directory is not an endorsement.